Liang Yu
Clayton, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Toll-like Receptor 9 Promotes Initiation of Gastric Tumorigenesis by Augmenting Inflammation and Cellular Proliferation.
Journal: Cellular and molecular gastroenterology and hepatology
Published: February 07, 2021
STAT3-mediated upregulation of the AIM2 DNA sensor links innate immunity with cell migration to promote epithelial tumourigenesis.
Journal: Gut
Published: December 21, 2020
Oncogenic dependency on STAT3 serine phosphorylation in KRAS mutant lung cancer.
Journal: Oncogene
Published: October 30, 2020
TLR2 activation promotes tumour growth and associates with patient survival and chemotherapy response in pancreatic ductal adenocarcinoma.
Journal: Oncogene
Published: September 02, 2020
The ADAM17 protease promotes tobacco smoke carcinogen-induced lung tumorigenesis.
Journal: Carcinogenesis
Published: April 11, 2019
ADAM17 selectively activates the IL-6 trans-signaling/ERK MAPK axis in KRAS-addicted lung cancer.
Journal: EMBO molecular medicine
Published: March 06, 2019
Toll-like receptor 2 regulates metabolic reprogramming in gastric cancer via superoxide dismutase 2.
Toll-like receptor 2 regulates metabolic reprogramming in gastric cancer via superoxide dismutase 2.
Journal: International journal of cancer
Published: June 06, 2018
Hyperactive gp130/STAT3-driven gastric tumourigenesis promotes submucosal tertiary lymphoid structure development.
Journal: International journal of cancer
Published: October 05, 2017
TLR Agonists as Adjuvants for Cancer Vaccines.
Journal: Advances in experimental medicine and biology
Published: September 19, 2017
Clinical Utility of a STAT3-Regulated miRNA-200 Family Signature with Prognostic Potential in Early Gastric Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 24, 2017
Last Updated: 09/26/2026